Prospective study of special stage II (T 2b-3 N 0 M 0 ) non-small-cell lung cancer treated with hypofractionated-simultaneous integrated boost-intensity modulated radiation therapy | Zendy

Baosheng Li | Zendy; Wei Zhang | Zendy; Chengxin Liu | Zendy; Haiqun Lin | Zendy; Yipeng Song | Zendy; Wei Huang | Zendy; Hongsheng Li | Zendy; Miaomiao Li | Zendy

Open Access

Prospective study of special stage II (T _2b-3 N ₀ M ₀ ) non-small-cell lung cancer treated with hypofractionated-simultaneous integrated boost-intensity modulated radiation therapy

Author(s) -

Baosheng Li,

Wei Zhang,

Chengxin Liu,

Haiqun Lin,

Yipeng Song,

Wei Huang,

Hongsheng Li,

Miaomiao Li

Publication year - 2015

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.157332

Subject(s) - stage (stratigraphy) , lung cancer , intensity (physics) , medicine , nuclear medicine , oncology , cancer research , physics , biology , optics , paleontology

To analyze the effects of hypofractionated-simultaneous integrated boost-intensity modulated radiation therapy (Hypo-SIB-IMRT) on medically inoperable patients with special stage II (T2b-3N0M0) non-smallcell lung cancer (NSCLC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research